Literature DB >> 11738294

The healing process of infarct-related plaques. Insights from 18 months of serial angioscopic follow-up.

Y Ueda1, M Asakura, O Yamaguchi, A Hirayama, M Hori, K Kodama.   

Abstract

OBJECTIVES: To clarify the healing process of disrupted culprit plaques of acute myocardial infarction (MI), we serially observed the culprit plaques for 18 months after the onset of acute MI by angioscopy.
BACKGROUND: Although it has been reported that disruption of the yellow plaque and subsequent thrombosis cause acute MI and that the thrombogenicity of the plaque lasts for a month, the healing process of the plaque after disruption has not been clarified.
METHODS: Eighty-five patients with acute MI were prospectively and consecutively enrolled. Angioscopic studies were performed immediately and at 1, 6 and 18 months after successful reperfusion. The prevalence of yellow plaques and thrombus was examined. The color grade of the plaque was determined as 0 (white), 1 (light yellow), 2 (yellow) or 3 (bright yellow).
RESULTS: Although yellow plaque was present at the culprit lesion in most patients throughout follow-up, its color grade was reduced from one to six months (1.9 +/- 0.6 vs. 1.1 +/- 0.7, p = 0.0003) after reperfusion, especially in the patients without hyperlipidemia (HL). The incidence of thrombus was 92.5% immediately after reperfusion, which was reduced significantly to 63.8%, 4.8% and 11.8% at 1, 6 and 18 months, respectively. The incidence of thrombus (77.8% vs. 45.0%, p = 0.03) at one month was higher in the patients with diabetes mellitus (DM).
CONCLUSIONS: The healing process of yellow plaques at the culprit lesions of MI was detected by angioscopy as reductions of color grade and thrombogenicity at six months and partially at one month after the onset of acute MI. This healing process appears to deteriorate by complicating cases of DM or HL.

Entities:  

Mesh:

Year:  2001        PMID: 11738294     DOI: 10.1016/s0735-1097(01)01673-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Ex vivo comparison of angioscopy and histopathology for the evaluation of coronary plaque characteristics.

Authors:  Masahiko Shibuya; Kenichi Fujii; Hiroyuki Hao; Takahiro Imanaka; Masashi Fukunaga; Kojiro Miki; Hiroto Tamaru; Tsuyoshi Nakata; Hisashi Sawada; Yoshiro Naito; Seiichi Hirota; Tohru Masuyama
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-12       Impact factor: 2.357

Review 2.  Optical coherence tomography for imaging the vulnerable plaque.

Authors:  Guillermo J Tearney; Ik-Kyung Jang; Brett E Bouma
Journal:  J Biomed Opt       Date:  2006 Mar-Apr       Impact factor: 3.170

3.  Diagnostic importance of platelet parameters in patients with acute coronary syndrome admitted to a tertiary care hospital in southwest region, Saudi Arabia.

Authors:  Abdullah S Assiri; Abdul-Moneim Jamil; Ahmed A Mahfouz; Zizi S Mahmoud; Mohamed Ghallab
Journal:  J Saudi Heart Assoc       Date:  2011-10-20

4.  Clinical significance of microvessels detected by in vivo optical coherence tomography within human atherosclerotic coronary arterial intima: a study with multimodality intravascular imagings.

Authors:  Toshihiko Nishida; Takafumi Hiro; Tadateru Takayama; Mitsumasa Sudo; Hironori Haruta; Daisuke Fukamachi; Atsushi Hirayama; Yasuo Okumura
Journal:  Heart Vessels       Date:  2021-01-06       Impact factor: 2.037

5.  A higher colour grade yellow plaque was detected at one year after implantation of an everolimus-eluting stent than after a zotarolimus-eluting stent.

Authors:  Koshi Matsuo; Yasunori Ueda; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Heart Asia       Date:  2013-09-07

6.  Effect of drug-coated balloon angioplasty on in-stent restenotic coronary lesions analyzed with optical coherence tomography and serial coronary artery angioscopy.

Authors:  Naotaka Akutsu; Akihito Ogaku; Yutaka Koyama; Hidesato Fujito; Yasunari Ebuchi; Suguru Migita; Tomoyuki Morikawa; Takehiro Tamaki; Takashi Mineki; Takaaki Kougo; Keisuke Kojima; Korehito Iida; Nobuhiro Murata; Toshihiko Nishida; Toru Oshima; Mitsumasa Sudo; Daisuke Kitano; Hironori Haruta; Daisuke Fukamachi; Tadateru Takayama; Takafumi Hiro; Atsushi Hirayama; Yasuo Okumura
Journal:  Heart Vessels       Date:  2019-06-15       Impact factor: 2.037

7.  Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation).

Authors:  Yoshiro Tsukiyama; Toshiro Shinke; Takayuki Ishihara; Hiromasa Otake; Daisuke Terashita; Amane Kozuki; Masashi Fukunaga; Kan Zen; Tetsuo Horimatsu; Kenichi Fujii; Junya Shite; Masaaki Uematsu; Mitsuyoshi Takahara; Osamu Iida; Shinsuke Nanto; Ken-Ichi Hirata
Journal:  Int J Cardiovasc Imaging       Date:  2019-06-14       Impact factor: 2.357

8.  Chronic kidney disease and coronary artery vulnerable plaques.

Authors:  Mitsuru Wada; Yasunori Ueda; Tomoaki Higo; Koshi Matsuo; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Toshikazu Kashiyama; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

9.  Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy.

Authors:  Tadateru Takayama; Takafumi Hiro; Yasunori Ueda; Satoshi Saito; Kazuhisa Kodama; Sei Komatsu; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

10.  Clinical Importance of the LDL-C/Apolipoprotein B Ratio for Neointimal Formation after Everolimus-Eluting Stent Implantations.

Authors:  Naotaka Akutsu; Koichiro Hori; Saki Mizobuchi; Akihito Ogaku; Yutaka Koyama; Hidesato Fujito; Riku Arai; Yasunari Ebuchi; Suguru Migita; Tomoyuki Morikawa; Takehiro Tamaki; Keisuke Kojima; Nobuhiro Murata; Toshihiko Nishida; Daisuke Kitano; Daisuke Fukamachi; Yasuo Okumura
Journal:  J Atheroscler Thromb       Date:  2021-03-21       Impact factor: 4.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.